Advertisement

Post-traumatic Stress Disorder

  • Mine Sahingoz
  • Serap Sari
Chapter

Abstract

Post-traumatic stress disorder (PTSD) may be a significant mental health concern for pregnant and postpartum women. A number of studies have shown that PTSD can have a negative impact on women, their relationship and birth outcomes. Furthermore, there are as well evidence that it may also affect infant emotion regulation and development. Although there has been extensive amount of research on the correlates of perinatal PTSD, the treatment of PTSD remains still unclear. This chapter presents recommendations for pharmacological treatment as well as the risks of untreated PTSD during the perinatal period for PTSD.

Keywords

Post-traumatic stress disorder Pregnancy Postpartum period Women Anxiety Lactation Treatment Pharmacotherapy 

References

  1. 1.
    Horsch A, Brooks C, Fletcher H. Maternal coping, appraisals and adjustment following diagnosis of fetal anomaly. Prenat Diagn. 2013;33:1137–45.PubMedGoogle Scholar
  2. 2.
    Mahenge B, Likindikoki S, Stöckl H, Mbwambo J. Intimate partner violence during pregnancy and associated mental health symptoms among pregnant women in Tanzania: a cross-sectional study. BJOG. 2013;120:940–6.PubMedGoogle Scholar
  3. 3.
    Schwab W, Marth C, Bergant AM. Post-traumatic stress disorder postpartum: the impact of birth on the prevalence of post-traumatic stress disorder (PTSD) in multiparous women. Geburtshilfe Frauenheilkd. 2012;72(1):56–63.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Verreault N, Da Costa D, Marchand A, Ireland K, Banack H, Dritsa M, Khalifé S. PTSD following childbirth: a prospective study of incidence and risk factors in Canadian women. J Psychosom Res. 2012;73:257–63.PubMedGoogle Scholar
  5. 5.
    Howard LM, Molyneaux E, Dennis CL, Rochat T, Stein A, Milgrom J. Non-psychotic mental disorders in the perinatal period. Lancet. 2014;384(9956):1775–88.PubMedGoogle Scholar
  6. 6.
    Halvorsen L, Nerum H, Oian P, Sørlie T. Giving birth with rape in one’s past: a qualitative study. Birth. 2013;40:182–91.PubMedGoogle Scholar
  7. 7.
    Cerulli C, Talbot NL, Tang W, Chaudron LH. Co-occurring intimate partner violence and mental health diagnoses in perinatal women. J Women’s Health. 2011;20:1797–803.Google Scholar
  8. 8.
    Grekin R, O’Hara MW. Prevalence and risk factors of postpartum posttraumatic stress disorder: a meta-analysis. Clin Psychol Rev. 2014;34:389–401.PubMedGoogle Scholar
  9. 9.
    van Son M, Verkerk G, van der Hart O, Komproe I, Pop V. Prenatal depression, mode of delivery and perinatal dissociation as predictors of postpartum posttraumatic stress: an empirical study. Clin Psychol Psychother. 2005;12:297–312.Google Scholar
  10. 10.
    Shaw JG, Asch SM, Kimerling R, Frayne SM, Shaw KA, Phibbs CS. Posttraumatic stress disorder and risk of spontaneous preterm birth. Obstet Gynecol. 2014;124:1111–9.PubMedGoogle Scholar
  11. 11.
    Yonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, Belanger K. Pregnant women with posttraumatic stress disorder and risk of preterm birth. JAMA Psychiat. 2014;71:897–904.Google Scholar
  12. 12.
    Davies J, Slade P, Wright I, Stewart P. Posttraumatic stress symptoms following childbirth and mothers’ perceptions of their infants. Infant Ment Health J. 2008;29:537–54.PubMedGoogle Scholar
  13. 13.
    Ionio C, Blasio PD. Post-traumatic stress symptoms after childbirth and early mother–child interactions: an exploratory study. J Reprod Infant Psychol. 2014;32:163–81.Google Scholar
  14. 14.
    Bosquet Enlow M, Kitts RL, Blood E, Bizarro A, Hofmeister M, Wright RJ. Maternal posttraumatic stress symptoms and infant emotional reactivity and emotion regulation. Infant Behav Dev. 2011;34:487–503.PubMedGoogle Scholar
  15. 15.
    Garthus-Niegel S, Ayers S, Martini J, von Soest T, Eberhard-Gran M. The impact of postpartum post-traumatic stress disorder symptoms on child development: a population-based, 2-year follow-up study. Psychol Med. 2017;47:161–70.PubMedGoogle Scholar
  16. 16.
    Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048–60.Google Scholar
  17. 17.
    Marmar CR, Schlenger W, Henn-Haase C, Qian M, Purchia E, Li M, Corry N, Williams CS, Ho CL, Horesh D, Karstoft KI, Shalev A, Kulka RA. Course of posttraumatic stress disorder 40 years after the Vietnam War: findings from the National Vietnam Veterans Longitudinal Study. JAMA Psychiat. 2015;72:875–81.Google Scholar
  18. 18.
    Galatzer-Levy IR, Nickerson A, Litz BT, Marmar CR. Patterns of lifetime PTSD comorbidity: a latent class analysis. Depress Anxiety. 2013;30:489–96.PubMedGoogle Scholar
  19. 19.
    Gallagher MW, Brown TA. Bayesian analysis of current and lifetime comorbidity rates of mood and anxiety disorders in individuals with posttraumatic stress disorder. J Psychopathol Behav Assess. 2015;37:60–6.PubMedGoogle Scholar
  20. 20.
    Yarvis JS, Schiess L. Subthreshold posttraumatic stress disorder (PTSD) as a predictor of depression, alcohol use, and health problems in veterans. J Workplace Behav Health. 2008;23:395–424.Google Scholar
  21. 21.
    Morland L, Goebert D, Onoye J, Frattarelli L, Derauf C, Herbst M, Matsu C, Friedman M. Posttraumatic stress disorder and pregnancy health: preliminary update and implications. Psychosomatics. 2007;48:304–8.PubMedGoogle Scholar
  22. 22.
    Alder J, Fink N, Bitzer J, Hösli I, Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 2007;20:189–209.PubMedGoogle Scholar
  23. 23.
    Dunkel Schetter C, Tanner L. Anxiety, depression and stress in pregnancy: implications for mothers, children, research, and practice. Curr Opin Psychiatry. 2012;25:141–8.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Cook N, Ayers S, Horsch A. Maternal posttraumatic stress disorder during the perinatal period and child outcomes: a systematic review. J Affect Disord. 2018;225:18–31.PubMedGoogle Scholar
  25. 25.
    Engel SM, Berkowitz GS, Wolff MS, Yehuda R. Psychological trauma associated with the World Trade Center attacks and its effect on pregnancy outcome. Paediatr Perinat Epidemiol. 2005;19:334–41.PubMedGoogle Scholar
  26. 26.
    Ding XX, Wu YL, Xu SJ, Zhu RP, Jia XM, Zhang SF, Huang K, Zhu P, Hao JH, Tao FB. Maternal anxiety during pregnancy and adverse birth outcomes: a systematic review and meta-analysis of prospective cohort studies. J Affect Disord. 2014;159:103–10.PubMedGoogle Scholar
  27. 27.
    Glover V. Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv Neurobiol. 2015;10:269–83.PubMedGoogle Scholar
  28. 28.
    Anderson C, Cacola P. Implications of preterm birth for maternal mental health and infant development. Am J Matern Child Nurs. 2017;42:108–14.Google Scholar
  29. 29.
    Ayers S, Eagle A, Waring H. The effects of childbirth-related post-traumatic stress disorder on women and their relationships: a qualitative study. Psychol Health Med. 2006;11:389–98.PubMedGoogle Scholar
  30. 30.
    Beck CT, Gable RK, Sakala C, Declercq ER. Posttraumatic stress disorder in new mothers: results from a two-stage U.S. National Survey. Birth. 2011;38:216–27.PubMedGoogle Scholar
  31. 31.
    Beck CT, Watson S. Impact of birth trauma on breast-feeding: a tale of two pathways. Nurs Res. 2008;57:228–36.PubMedGoogle Scholar
  32. 32.
    Creedy DK, Shochet IM, Horsfall J. Childbirth and the development of acute trauma symptoms: incidence and contributing factors. Birth. 2000;27:104–11.PubMedGoogle Scholar
  33. 33.
    Fenech G, Thomson G. Tormented by ghosts from their past’: a meta-synthesis to explore the psychosocial implications of a traumatic birth on maternal well-being. Midwifery. 2014;30(2):185–93.PubMedGoogle Scholar
  34. 34.
    Nicholls K, Ayers S. Childbirth-related post-traumatic stress disorder in couples: a qualitative study. Br J Health Psychol. 2007;12(Pt 4):491–509.PubMedGoogle Scholar
  35. 35.
    Ayers S, Ford E. In: ed WA, editor. Oxford handbook of perinatal psychology Post-traumatic stress during pregnancy and the postpartum period. Cary, NC: Oxford University Press; 2014.Google Scholar
  36. 36.
    Koen N, Brittain K, Donald KA, Barnett W, Koopowitz S, Maré K, Zar HJ, Stein DJ. Psychological trauma and posttraumatic stress disorder: risk factors and associations with birth outcomes in the Drakenstein Child Health Study. Eur J Psychotraumatol. 2016;7:28720.PubMedGoogle Scholar
  37. 37.
    Parfitt Y, Pike A, Ayers S. Infant developmental outcomes: a family systems perspective. Infant Child Dev. 2014;23:353–73.Google Scholar
  38. 38.
    Australian Centre for Posttraumatic Mental Health. The Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder. Melbourne, VIC: Australian Centre for Posttraumatic Mental Health (ACPMH); 2013.Google Scholar
  39. 39.
    World Health Organization. Guidelines for the management of conditions specifically related to stress. Geneva: World Health Organization Press (WHO Press; 2013.Google Scholar
  40. 40.
    Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J, Mortensen EL. Long-term treatment effect of trauma-affected refugees with flexible cognitive behavioural therapy and antidepressants. Psychiatry Res. 2018;264:217–23.PubMedGoogle Scholar
  41. 41.
    Chen YR, Hung KW, Tsai JC, Chu H, Chung MH, Chen SR, Liao YM, Ou KL, Chang YC, Chou KR. Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: a meta-analysis of randomized controlled trials. PLoS One. 2014;9:103676.Google Scholar
  42. 42.
    Cusack K, Jonas DE, Forneris CA, Wines C, Sonis J, Middleton JC, Feltner C, Brownley KA, Olmsted KR, Greenblatt A, Weil A, Gaynes BN. Psychological treatments for adults with posttraumatic stress disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2016;43:128–41.PubMedGoogle Scholar
  43. 43.
    Gamble JA, Creedy DK, Webster J, Moyle W. A review of the literature on debriefing or non-directive counselling to prevent postpartum emotional distress. Midwifery. 2002;18:72–9.PubMedGoogle Scholar
  44. 44.
    Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. 2015;206:93–100.PubMedGoogle Scholar
  45. 45.
    Bowers ME, Ressler KJ. An overview of translationally informed treatments for posttraumatic stress disorder: animal models of pavlovian fear conditioning to human clinical trials. Biol Psychiatry. 2015;78:15–27.Google Scholar
  46. 46.
    Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, Christmas DM, Davies S, Fineberg N, Lidbetter N, Malizia A, McCrone P, Nabarro D, O’Neill C, Scott J, van der Wee N, Wittchen HU. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28:403–39.PubMedGoogle Scholar
  47. 47.
    Davidson J. Pharmacotherapy of post-traumatic stress disorder: going beyond the guidelines. BJPsych Open. 2016;2:16–8.Google Scholar
  48. 48.
    Jeffreys M, Capehart B, Friedman MJ. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications. J Rehabil Res Dev. 2012;49:703–15.PubMedGoogle Scholar
  49. 49.
    Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74:541–50.Google Scholar
  50. 50.
    Ipser JC, Stein DJ. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012;15:825–40.PubMedGoogle Scholar
  51. 51.
    Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder, Board on the Health of Select Populations, Institute of Medicine. Treatment for posttraumatic stress disorder in military and veteran populations. Final assessment. Washington, DC: National Academies Press (US); 2014.Google Scholar
  52. 52.
    Davidson JR, Bernik M, Connor KM, Friedman MJ, Jobson KO, Kim Y, Lecrubier Y, Ma H, Njenga F, Stein DJ. A new treatment algorithm for posttraumatic stress disorder. Psychiatr Ann. 2005;35:887–98.Google Scholar
  53. 53.
    Martenyi F, Brown EB, Zhang H, Koke SC, Prakash A. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry. 2002;181:315–20.PubMedGoogle Scholar
  54. 54.
    Martenyi F, Soldatenkova V. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: analysis of the veteran group of a placebo-controlled, randomized clinical trial. Eur Neuropsychopharmacol. 2006;16:340–9.PubMedGoogle Scholar
  55. 55.
    Buhmann CB, Andersen HS. Diagnosing and treating post-traumatic stress disorder. Ugeskr Laeger. 2017;179(24):V12160914.PubMedGoogle Scholar
  56. 56.
    Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006;63:1158–65.PubMedGoogle Scholar
  57. 57.
    Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments. Depress Anxiety. 2016;33:792–806.PubMedGoogle Scholar
  58. 58.
    Escalona R, Canive JM, Calais LA, Davidson JR. Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. Depress Anxiety. 2002;15:29–33.PubMedGoogle Scholar
  59. 59.
    Shalev AY, Ankri Y, Israeli-Shalev Y, Peleg T, Adessky R, Freedman S. Prevention of posttraumatic stress disorder by early treatment: results from the Jerusalem Trauma Outreach and Prevention study. Arch Gen Psychiatry. 2012;69:166–76.PubMedGoogle Scholar
  60. 60.
    Neylan TC, Metzler TJ, Schoenfeld FB, Weiss DS, Lenoci M, Best SR, Lipsey TL, Marmar CR. Fluvoxamine and sleep disturbances in posttraumatic stress disorder. J Trauma Stress. 2001;14:461–7.PubMedGoogle Scholar
  61. 61.
    McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, Green L, Gregoire A, Howard LM, Jones I, Khalifeh H, Lingford-Hughes A, Mcdonald E, Micali N, Pariante CM, Peters L, Roberts A, Smith NC, Taylor D, Wieck A, Yates LM, Young AH, Endorsed by the British Association for Psychopharmacology. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum. J Psychopharmacol. 2017;31:519–52.PubMedGoogle Scholar
  62. 62.
    Jain AE, Lacy T. Psychotropic drugs in pregnancy and lactation. J Psychiatr Pract. 2005;11:177–91.PubMedGoogle Scholar
  63. 63.
    Womersley K, Ripullone K, Agius M. What are the risks associated with different selective serotonin re-uptake inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Psychiatr Danub. 2017;29(Suppl 3):629–44.PubMedGoogle Scholar
  64. 64.
    Larsen ER, Damkier P, Pedersen LH, Fenger-Gron J, Mikkelsen RL, Nielsen RE, Linde VJ, Knudsen HE, Skaarup L, Videbech P, Danish Psychiatric Society; Danish Society of Obstetrics and Gynecology; Danish Paediatric Society; Danish Society of Clinical Pharmacology. Use of psychotropic drugs during pregnancy and breast-feeding. Acta Psychiatr Scand. 2015;445:1–28.Google Scholar
  65. 65.
    Einarson A, Choi J, Einarson TR, Koren G. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatr. 2009;54:242–6.Google Scholar
  66. 66.
    Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, Mastroiacovo P, Addis A, Matsui D, Schuler L, Einarson TR, Koren G. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry. 2001;158:1728–30.PubMedGoogle Scholar
  67. 67.
    Ram D, Gandotra S. Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation. Indian J Psychiatry. 2015;57(Suppl 2):354–71.Google Scholar
  68. 68.
    Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, Saunders WB, Cavenar JO Jr. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47:259–66.PubMedGoogle Scholar
  69. 69.
    Reist C, Kauffmann CD, Haler RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, Nelson JN. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry. 1989;146:513–6.PubMedGoogle Scholar
  70. 70.
    Sullivan GM, Neria Y. Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials. Curr Opin Investig Drugs. 2009;10:35–45.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Davidson J. Vintage treatments for PTSD: a reconsideration of tricyclic drugs. J Psychopharmacol. 2015;29(3):264–9.PubMedGoogle Scholar
  72. 72.
    Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL Jr. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179:366–70.PubMedGoogle Scholar
  73. 73.
    Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res. 1988;24(2):149–55.PubMedGoogle Scholar
  74. 74.
    Baker DG, Diamond BI, Gillette G, Hamner M, Katzelnick D, Keller T, Mellman TA, Pontius E, Rosenthal M, Tucker P, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology. 1995;122:386–9.PubMedGoogle Scholar
  75. 75.
    Katz RJ, Lott MH, Arbus P, Crocq L, Herlobsen P, Lingjaerde O, Lopez G, Loughrey GC, MacFarlane DJ, McIvor R, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1:169–74.PubMedGoogle Scholar
  76. 76.
    Ornoy A, Weinstein-Fudim L, Ergaz Z. Antidepressants, antipsychotics, and mood stabilizers in pregnancy: what do we know and how should we treat pregnant women with depression. Birth Defects Res. 2017;109:933–56.PubMedGoogle Scholar
  77. 77.
    Gentile S. On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr. 2010;15:167–85.PubMedGoogle Scholar
  78. 78.
    Eberhard-Gran M, Eskild A, Opjordsmoen S. Use of psychotropic medications in treating mood disorders during lactation : practical recommendations. CNS Drugs. 2006;20:187–98.PubMedGoogle Scholar
  79. 79.
    Uguz F. Poor feeding and severe sedation in a newborn nursed by a mother on a low dose of amitriptyline. Breastfeed Med. 2017;12:67–8.PubMedGoogle Scholar
  80. 80.
    Bauer RL, Orfei J, Wichman CL. Use of transdermal selegiline in pregnancy and lactation: a case report. Psychosomatics. 2017;58:450–2.PubMedGoogle Scholar
  81. 81.
    Kennedy D, Webster WS, Hill M, Ritchie HE. Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: case report and literature review. Reprod Toxicol. 2017;69:146–9.PubMedGoogle Scholar
  82. 82.
    Lusskin SI, Khan SJ, Ernst C, Habib S, Fersh ME, Albertini ES. Pharmacotherapy for perinatal depression. Clin Obstet Gynecol. 2018;61(3):544–61.PubMedGoogle Scholar
  83. 83.
    Detweiler MB, Pagadala B, Candelario J, Boyle JS, Detweiler JG, Lutgens BW. Treatment of post-traumatic stress disorder nightmares at a veterans affairs medical center. J Clin Med. 2016;5(12):pii: E117.Google Scholar
  84. 84.
    Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry. 2001;34:128–31.PubMedGoogle Scholar
  85. 85.
    Einarson A, Bonari L, Voyer-Lavigne S, Addis A, Matsui D, Johnson Y, Koren G. A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatr. 2003;48:106–10.Google Scholar
  86. 86.
    Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation – a systematic review. Eur Neuropsychopharmacol. 2016;26:126–35.PubMedGoogle Scholar
  87. 87.
    Klier CM, Mossaheb N, Lee A, Zernig G. Mirtazapine and breastfeeding: maternal and infant plasma levels. Am J Psychiatry. 2007;164:348–9.PubMedGoogle Scholar
  88. 88.
    Kristensen JH, Ilett KF, Rampono J, Kohan R, Hackett LP. Transfer of the antidepressant mirtazapine into breast milk. Br J Clin Pharmacol. 2007;63:322–7.PubMedPubMedCentralGoogle Scholar
  89. 89.
    Ahearn EP, Juergens T, Cordes T, Becker T, Krahn D. A review of atypical antipsychotic medications for posttraumatic stress disorder. Int Clin Psychopharmacol. 2011;26:193–200.PubMedGoogle Scholar
  90. 90.
    Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33:169–80.Google Scholar
  91. 91.
    Carey P, Suliman S, Ganesan K, Seedat S, Stein DJ. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study. Hum Psychopharmacol. 2012;27:386–91.PubMedGoogle Scholar
  92. 92.
    Hamner MB, Frueh BC, Ulmer HG, Arana GW. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999;45:846–52.PubMedGoogle Scholar
  93. 93.
    Hamner MB, Faldowski RA, Ulmer HG, Frueh BC, Huber MG, Arana GW. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003;18:1–8.PubMedGoogle Scholar
  94. 94.
    Hermes E, Sernyak M, Rosenheck R. The use of second generation antipsychotics for post-traumatic stress disorder in a US Veterans Health Administration Medical Center. Epidemiol Psychiatr Sci. 2014;23(3):281–8.PubMedGoogle Scholar
  95. 95.
    Koek RJ, Schwartz HN, Scully S, Langevin JP, Spangler S, Korotinsky A, Jou K, Leuchter A. Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Prog Neuro-Psychopharmacol Biol Psychiatry. 2016;70:170–218.Google Scholar
  96. 96.
    Reich DB, Winternitz S, Hennen J, Watts T, Stanculescu C. A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry. 2004;65:1601–6.PubMedGoogle Scholar
  97. 97.
    Padala PR, Madison J, Monnahan M, Marcil W, Price P, Ramaswamy S, Din AU, Wilson DR, Petty F. Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol. 2006;21(5):275–80.PubMedGoogle Scholar
  98. 98.
    Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008;69:520–5.PubMedGoogle Scholar
  99. 99.
    Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159:1777–9.PubMedGoogle Scholar
  100. 100.
    Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16:197–203.PubMedGoogle Scholar
  101. 101.
    Hamner MB, Deitsch SE, Brodrick PS, Ulmer HG, Lorberbaum JP. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol. 2003b;23:15–20.PubMedGoogle Scholar
  102. 102.
    Sokolski KN, Denson TF, Lee RT, Reist C. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder. Mil Med. 2003;168:486–9.PubMedGoogle Scholar
  103. 103.
    Britnell SR, Jackson AD, Brown JN, Capehart BP. Aripiprazole for post-traumatic stress disorder: a systematic review. Clin Neuropharmacol. 2017;40:273–8.PubMedGoogle Scholar
  104. 104.
    Kellner M, Muhtz C, Wiedemann K. Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial? J Clin Psychopharmacol. 2010;30:471–3.PubMedGoogle Scholar
  105. 105.
    Gentile S. Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother. 2004;38:1265–71.PubMedGoogle Scholar
  106. 106.
    McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66:444–9.PubMedGoogle Scholar
  107. 107.
    Taylor FB, Martin P, Thompson C, Williams J, Mellman TA, Gross C, Peskind ER, Raskind MA. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008;63:629–32.PubMedGoogle Scholar
  108. 108.
    Raskind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D, Shofer J, O’Connell J, Taylor F, Gross C, Rohde K, McFall ME. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928–34.PubMedGoogle Scholar
  109. 109.
    Bajor LA, Ticlea AN, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder. Harv Rev Psychiatry. 2011;19:240–58.PubMedGoogle Scholar
  110. 110.
    Alao A, Selvarajah J, Razi S. The use of clonidine in the treatment of nightmares among patients with co-morbid PTSD and traumatic brain injury. Int J Psychiatry Med. 2012;44:165–9.PubMedGoogle Scholar
  111. 111.
    Neylan TC, Lenoci M, Samuelson KW, Metzler TJ, Henn-Haase C, Hierholzer RW, Lindley SE, Otte C, Schoenfeld FB, Yesavage JA, Marmar CR. No improvement of posttraumatic stress disorder symptoms with guanfacine treatment. Am J Psychiatry. 2006;163:2186–8.PubMedGoogle Scholar
  112. 112.
    Lubbe WF, Hodge JV. Combined alpha- and beta-adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy. N Z Med J. 1981;94(691):169–72.PubMedGoogle Scholar
  113. 113.
    Pitman RK, Sanders KM, Zusman RM, Healy AR, Cheema F, Lasko NB, Cahill L, Orr SP. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry. 2002;51:189–92.PubMedGoogle Scholar
  114. 114.
    Hoge EA, Worthington JJ, Nagurney JT, Chang Y, Kay EB, Feterowski CM, Katzman AR, Goetz JM, Rosasco ML, Lasko NB, Zusman RM, Pollack MH, Orr SP, Pitman RK. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012;18:21–7.PubMedGoogle Scholar
  115. 115.
    Brunet A, Thomas É, Saumier D, Ashbaugh AR, Azzoug A, Pitman RK, Orr SP, Tremblay J. Trauma reactivation plus propranolol is associated with durably low physiological responding during subsequent script-driven traumatic imagery. Can J Psychiatr. 2014;59:228–32.Google Scholar
  116. 116.
    Ferrero S, Colombo BM, Ragni N. Maternal arrhythmias during pregnancy. Arch Gynecol Obstet. 2004;269:244–53.PubMedGoogle Scholar
  117. 117.
    Meidahl Petersen K, Jimenez-Solem E, Andersen JT, Petersen M, Brødbæk K, Køber L, Torp-Pedersen C, Poulsen HE. β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open. 2012;2(4):e001185.PubMedPubMedCentralGoogle Scholar
  118. 118.
    Taylor EA, Turner P. Anti-hypertensive therapy with propranolol during pregnancy and lactation. Postgrad Med J. 1981;57(669):427–30.PubMedPubMedCentralGoogle Scholar
  119. 119.
    Thorley KJ, McAinsh J. Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharm Drug Dispos. 1983;4:299–301.PubMedGoogle Scholar
  120. 120.
    Alsaad AM, Chaudhry SA, Koren G. First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis. Reprod Toxicol. 2015;53:45–50.PubMedGoogle Scholar
  121. 121.
    Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Pennell PB, Bateman BT, Patorno E. Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study. Neurology. 2018;90:342–51.Google Scholar
  122. 122.
    Gentile S. Topiramate in pregnancy and breastfeeding. Clin Drug Investig. 2009;29:139–41.Google Scholar
  123. 123.
    Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P. Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology. 2011;76:1817–23.PubMedGoogle Scholar
  124. 124.
    Davanzo R, Dal Bo S, Bua J, Copertino M, Zanelli E, Matarazzo L. Antiepileptic drugs and breastfeeding. Ital J Pediatr. 2013;39:50.PubMedPubMedCentralGoogle Scholar
  125. 125.
    Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O’Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1.PubMedPubMedCentralGoogle Scholar
  126. 126.
    Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011;72(7):892–7.PubMedGoogle Scholar
  127. 127.
    Foa EB, Keane TM, Friedman MJ, Cohen JA. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies. 2nd ed. New York, NY: Guilford; 2008.Google Scholar
  128. 128.
    Bernardy NC, Friedman MJ. Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned? Curr Psychiatry Rep. 2015;17:564.PubMedGoogle Scholar
  129. 129.
    Kerbage H, Richa S. Non-antidepressant long-term treatment in post-traumatic stress disorder (PTSD). Curr Clin Pharmacol. 2015;10:116–25.PubMedGoogle Scholar
  130. 130.
    de Vries GJ, Olff M. The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands. J Trauma Stress. 2009;22:259–67.PubMedGoogle Scholar
  131. 131.
    Frans O, Rimmö PA, Aberg L, Fredrikson M. Trauma exposure and post-traumatic stress disorder in the general population. Acta Psychiatr Scand. 2005;111:291–9.PubMedGoogle Scholar
  132. 132.
    Birur B, Moore NC, Davis LL. An evidence-based review of early intervention and prevention of posttraumatic stress disorder. Community Ment Health J. 2017;53:183–201.PubMedGoogle Scholar
  133. 133.
    Horn SR, Charney DS, Feder A. Understanding resilience: new approaches for preventing and treating PTSD. Exp Neurol. 2016;284(Pt B):119–32.PubMedGoogle Scholar
  134. 134.
    Qi W, Gevonden M, Shalev A. Prevention of post-traumatic stress disorder after trauma: current evidence and future directions. Curr Psychiatry Rep. 2016;18(2):20.PubMedPubMedCentralGoogle Scholar
  135. 135.
    Roberts NP, Kitchiner NJ, Kenardy J, Bisson JI. Systematic review and meta-analysis of multiple-session early interventions following traumatic events. Am J Psychiatry. 2009;166:293–301.PubMedGoogle Scholar
  136. 136.
    Nash WP, Watson PJ. Review of VA/DOD clinical practice guideline on management of acute stress and interventions to prevent posttraumatic stress disorder. J Rehabil Res Dev. 2012;49:637–48.PubMedGoogle Scholar
  137. 137.
    Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A, Marmar CR. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry. 2003;54:947–9.PubMedGoogle Scholar
  138. 138.
    Nugent NR, Christopher NC, Crow JP, Browne L, Ostrowski S, Delahanty DL. The efficacy of early propranolol administration at reducing PTSD symptoms in pediatric injury patients: a pilot study. J Trauma Stress. 2010;23:282–7.PubMedPubMedCentralGoogle Scholar
  139. 139.
    Stein MB, Kerridge C, Dimsdale JE, Hoyt DB. Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients. J Trauma Stress. 2007;20:923–32.PubMedGoogle Scholar
  140. 140.
    Delahanty DL, Gabert-Quillen C, Ostrowski SA, Nugent NR, Fischer B, Morris A, Pitman RK, Bon J, Fallon W. The efficacy of initial hydrocortisone administration at preventing posttraumatic distress in adult trauma patients: a randomized trial. CNS Spectr. 2013;18:103–11.PubMedPubMedCentralGoogle Scholar
  141. 141.
    Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhäusler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol Psychiatry. 2001;50:978–85.PubMedGoogle Scholar
  142. 142.
    Schelling G, Stoll C, Kapfhammer HP, Rothenhäusler HB, Krauseneck T, Durst K, Haller M, Briegel J. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder and health-related quality of life in survivors. Crit Care Med. 1999;27:2678–83.PubMedGoogle Scholar
  143. 143.
    Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 1996;57:390–4.PubMedGoogle Scholar
  144. 144.
    Mellman TA, Bustamante V, David D, Fins AI. Hypnotic medication in the aftermath of trauma. J Clin Psychiatry. 2002;63:1183–4.PubMedGoogle Scholar
  145. 145.
    Stoddard FJ Jr, Luthra R, Sorrentino EA, Saxe GN, Drake J, Chang Y, Levine JB, Chedekel DS, Sheridan RL. A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children. J Child Adolesc Psychopharmacol. 2011;21:469–77.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Mine Sahingoz
    • 1
  • Serap Sari
    • 2
  1. 1.Department of Psychiatry, Meram Faculty of MedicineNecmettin Erbakan UniversityKonyaTurkey
  2. 2.Department of Psychiatry, Faculty of MedicineAtatürk UniversityErzurumTurkey

Personalised recommendations